-
EP3811959
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3811959
| EP3811959 - COMPOSITION FOR PREVENTING OR TREATING MUSCULAR DISEASES, CONTAINING, AS ACTIVE INGREDIENT, GLYCYRRHIZA URALENSIS EXTRACT OR COMPOUND ISOLATED THEREFROM [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 11.08.2023 Database last updated on 05.07.2024 | |
| Former | Request for examination was made Status updated on 26.03.2021 | ||
| Former | The international publication has been made Status updated on 25.12.2020 | Most recent event Tooltip | 05.07.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states Neo Cremar Co., Ltd. 211, Jungdae-ro Songpa-gu Seoul 05702 / KR | [N/P] |
| Former [2021/30] | For all designated states Neo Cremar Co., Ltd. 211, Jungdae-ro Songpa-gu Seoul 05702 / KR | ||
| Former [2021/29] | For all designated states Research Cooperation Foundation of Yeungnam University 280 (Dae-dong) Daehak-ro Gyeongsan-si, Gyeongsangbuk-do 38541 / KR | ||
| Former [2021/17] | For all designated states Research Cooperation Foundation of Yeungnam University 280 (Dae-dong) Daehak-ro Gyeongsan-si, Gyeongsangbuk-do 38541 / KR | ||
| For all designated states Korea Institute of Oriental Medicine 1672 Yuseong-daero Jeonmin-dong Yuseong-gu Daejeon 305-811 / KR | |||
| For all designated states Daegu Catholic University Industry Academic Cooperation Foundation 13-13, Hayang-ro Hayang-eup Gyeongsan-si Gyeongsangbuk-do 38430 / KR | Inventor(s) | 01 /
CHOI, Inho 110-805, 10, Jangsan-ro 4-gil Gyeongsan-si Gyeongsangbuk-do 38688 / KR | 02 /
LEE, Eun Ju 102-1806, 1008, Gachang-ro, Gachang-myeon Dalseong-gun Daegu 42936 / KR | 03 /
PARK, So-young 104-703, 33, Dalgubeol-daero 522-gil Suseong-gu Daegu 42078 / KR | 04 /
LEE, Yong-Ho 103-303, 3233, Dalgubeol-daero Suseong-gu Daegu 42271 / KR | 05 /
MA, Jin Yeul 102-1803, 63, Deongmyeong-ro Yuseong-gu Daejeon 34155 / KR | 06 /
CHO, Won-Kyung 202-903, 56, Innovalley-ro 29-gil Dong-gu Daegu 41064 / KR | 07 /
YANG, Hye Jin 713, 21, Oncheonbuk-ro 13beon-gil Yuseong-gu Daejeon 34185 / KR | [2021/17] | Representative(s) | Roos, Peter c/o Roospatent Noldinstrasse 7 81545 München / DE | [2021/17] | Application number, filing date | 20826227.9 | 17.06.2020 | [2021/17] | WO2020KR07826 | Priority number, date | KR20190072992 | 19.06.2019 Original published format: KR 20190072992 | KR20200073088 | 16.06.2020 Original published format: KR 20200073088 | KR20200073089 | 16.06.2020 Original published format: KR 20200073089 | KR20200073090 | 16.06.2020 Original published format: KR 20200073090 | KR20200073091 | 16.06.2020 Original published format: KR 20200073091 | KR20200073092 | 16.06.2020 Original published format: KR 20200073092 | [2021/17] | Filing language | KO | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020256397 | Date: | 24.12.2020 | Language: | KO | [2020/52] | Type: | A1 Application with search report | No.: | EP3811959 | Date: | 28.04.2021 | Language: | EN | [2021/17] | Search report(s) | International search report - published on: | KR | 24.12.2020 | (Supplementary) European search report - dispatched on: | EP | 02.05.2022 | Classification | IPC: | A61K36/484, A61K31/353, A61K31/12, A61P21/00, A23L33/105 | [2021/17] | CPC: |
A23L33/105 (EP,CN,US);
A61K36/484 (EP,CN,KR,US);
A23L33/40 (US);
A61K31/12 (EP,CN,US);
A61K31/353 (EP,CN,US);
A61K9/0056 (US);
A61P21/00 (EP,CN,KR,US);
A23V2002/00 (EP,US);
A61K2236/331 (EP,US);
A61K2236/333 (US);
A61K2236/37 (CN);
A61K2236/51 (CN);
A61K2236/53 (CN)
(-)
| C-Set: |
A23V2002/00, A23V2200/316, A23V2250/252 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/17] | Title | German: | ZUSAMMENSETZUNG ZUR VORBEUGUNG ODER BEHANDLUNG VON MUSKELERKRANKUNGEN MIT GLYCYRRHIZA-URALENSIS-EXTRAKT ODER ISOLIERTER VERBINDUNG DARAUS ALS WIRKSTOFF | [2021/17] | English: | COMPOSITION FOR PREVENTING OR TREATING MUSCULAR DISEASES, CONTAINING, AS ACTIVE INGREDIENT, GLYCYRRHIZA URALENSIS EXTRACT OR COMPOUND ISOLATED THEREFROM | [2021/17] | French: | COMPOSITION POUR LA PRÉVENTION OU LE TRAITEMENT DE MALADIES MUSCULAIRES, CONTENANT, EN TANT QUE PRINCIPE ACTIF, UN EXTRAIT DE GLYCYRRHIZA URALENSIS OU UN COMPOSÉ ISOLÉ DANS CELUI-CI | [2021/17] | Entry into regional phase | 21.01.2021 | Translation filed | 21.01.2021 | National basic fee paid | 21.01.2021 | Search fee paid | 21.01.2021 | Designation fee(s) paid | 21.01.2021 | Examination fee paid | Examination procedure | 21.01.2021 | Examination requested [2021/17] | 11.11.2022 | Amendment by applicant (claims and/or description) | 11.08.2023 | Despatch of a communication from the examining division (Time limit: M04) | 23.11.2023 | Reply to a communication from the examining division | 18.03.2024 | Despatch of a communication from the examining division (Time limit: M04) | 03.07.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 30.06.2022 | Renewal fee patent year 03 | 10.06.2023 | Renewal fee patent year 04 | 03.06.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]JP2012193157 (KANEKA CORP) [X] 1,6,8,9 * paragraphs [0031] , [0042] , [0016] , [0017] , [0024] , [0028] , [0035] , [0029] , [0030] , [0036] , [0037] , [0013]; claims 1,8,10,16; compound 3 * [I] 3-5,7,11; | [X]KR20170132475 (NAT UNIV CHONBUK IND COOP FOUND [KR]) [X] 1-16 * paragraphs [0005] , [0007] , [0009] , [0012] , [0015]; example 10; claims 1-3 * * paragraphs [0076] , [0085] , [0086]; figures 5-7,9,11,13; examples 2-8 * * paragraphs [0018] - [0022] - [0024] , [0026] , [0044]; example 1; claim 3 *; | [XI]WO2018079715 (SUNTORY HOLDINGS LTD [JP]) [X] 1,6,8-10,14-16 * paragraphs [0003] , [0004] , [0015] , [0022]; claims 1,2,4,9-11; table 1; compound 22 * [I] 2-5,7,11-13; | [XI] - PATERNI ILARIA ET AL, "Estrogen receptors alpha (ER[alpha]) and beta (ER[beta]): Subtype-selective ligands and clinical p", STEROIDS, ELSEVIER SCIENCE PUBLISHERS, NEW YORK, NY, US, (20140624), vol. 90, doi:10.1016/J.STEROIDS.2014.06.012, ISSN 0039-128X, pages 13 - 29, XP029048268 [X] 1,8,10,15,16 * page 15, column r, paragraph 5 * * page 24, column l, paragraph 5 * * page 22, column r, paragraphs 5-7 * [I] 2-7,9,11-14 DOI: http://dx.doi.org/10.1016/j.steroids.2014.06.012 | [A] - TANEMOTO RYUNOSUKE ET AL, "The constituents of licorice (Glycyrrhiza uralensis) differentially suppress nitric oxide production in interleukin-1[beta]-treated hepatocytes", BIOCHEMISTRY AND BIOPHYSICS REPORTS, vol. 2, doi:10.1016/j.bbrep.2015.06.004, ISSN 2405-5808, (20150615), pages 153 - 159, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668654/pdf/main.pdf, XP055912750 [A] 2,3,9-11,16 * page 154, column r, paragraphs 2-3; table 1 * DOI: http://dx.doi.org/10.1016/j.bbrep.2015.06.004 | [A] - TIANBAO CHEN ET AL, "The inhibitory effect of Isoliquiritigenin on the proliferation of human arterial smooth muscle cell", BMC PHARMACOLOGY AND TOXICOLOGY, BIOMED CENTRAL LTD, LONDON, UK, (20170717), vol. 18, no. 1, doi:10.1186/S40360-017-0165-2, pages 1 - 8, XP021246986 [A] 1,10 * page 3, column r, paragraph 2 * DOI: http://dx.doi.org/10.1186/s40360-017-0165-2 | [T] - LEE EUN JU ET AL, "Isolation and Characterization of Compounds from Glycyrrhiza uralensis as Therapeutic Agents for the Muscle Disorders", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Basel, CH, (20210101), vol. 22, no. 2, doi:10.3390/ijms22020876, ISSN 1661-6596, page 876, XP055913617 [T] 1-8,10-15 * the whole document * DOI: http://dx.doi.org/10.3390/ijms22020876 | International search | [Y]KR20060039036 (KYUNGPOOK NAT UNIV IND ACAD [KR]) [Y] 10-16 * See claim 3; paragraphs [0011] and [0013]; and figure 2. *; | [X]JP2009143838 (NIPPON MENAADE KESHOHIN KK) [X] 1-9 * See claim 1; and paragraphs [0013], [0018] and [0030]. *; | [A]KR20100101848 (KOREA RES INST OF BIOSCIENCE [KR]) [A] 1-16* See entire document. *; | [A]KR20100135424 (UNIV ULSAN FOUND FOR IND COOP [KR]) [A] 1-16 * See entire document. *; | [YX]JP2012193157 (KANEKA CORP) [Y] 10-16 * See abstract; claim 1; and paragraphs [0009], [0011], [0013], [0016], [0017], [0024] and [0042]. * [X] 1-9 |